SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX-25-D-9900 to DMS Pharmaceutical Group Inc. with CAGE code 1UNB0 for the supply of scopolamine transdermal patches identified by NSN 6505014562380 and associated NDC codes NDC00378-6470-99 and NDC00591-2258-04. The total contract value is $196.44 for three packages delivered by July 29, 2026, with FOB destination terms requiring the contractor to bear all transportation costs and risks until receipt at Fort Bragg, North Carolina. The order was issued as a small business set-aside with certification for both Women-Owned and Small Disadvantaged Business status, triggering applicable federal reporting obligations under FAR 19.7 and SBA compliance requirements. Packaging must be shipped via traceable means excluding parcel post, and all items must be marked with the required identifiers including W91KBP and Fort Bragg, NC, though no specific MIL-STD packaging or labeling standards are cited. Inspection and acceptance occur at the destination by government representatives, with payment processed through the Defense Finance and Accounting Service in Columbus, Ohio using a traditional voucher and check system. The contracting officer is Lisa Quinn, reachable via DLA email, and while no Contracting Officer’s Representative is named, an authorized government representative signature is required for receipt. No FAR clauses, special requirements, options, or detailed technical specifications beyond the product description and delivery terms are incorporated, reflecting a streamlined, low-value logistical procurement under a pre-existing basic ordering agreement.